Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Ampio Pharmaceuticals Inc. (AMPE)

Pharmaceutical Preparations

https://www.ampiopharma.com

Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the clinical development of Ampion and preclinical development. Its product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19-induced respiratory distress.

9800 MOUNT PYRAMID COURT, SUITE 400
ENGLEWOOD, CO

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/07/2003

Market Cap

1,703

Shares Outstanding

830,000

Weighted SO

832,021

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ALPN --.--%

ANTX --.--%

GLUE --.--%

CADL --.--%

SYBX --.--%

EFTR --.--%

GRTX --.--%

ICVX --.--%

ACIU --.--%

Beta

2.1940

Last Div

0.0000

Range

1.0E-4-7.47

Chg

0.0007

Avg Vol

2897

Mkt Cap

1703

Exch

AMEX

Country

US

Phone

720 437 6500

DCF Diff

-14.1199

DCF

15.9749

Div Yield

0.0000

P/S

0.0000

EV Multiple

0.4085

P/FV

0.0004

Div Yield %

0.0000

P/E

-0.0001

PEG

0.0000

Payout

0.0000

Current Ratio

2.3569

Quick Ratio

2.3569

Cash Ratio

1.7210

DSO

0.0000

DIO

0.0015

Op Cycle

0.0000

DPO

1117.3469

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0190

ROA

-1.4521

ROE

-1.4377

ROCE

-2.7071

NI/EBT

0.9649

EBT/EBIT

0.9490

EBIT/Rev

0.0000

Debt Ratio

0.0478

D/E

0.0815

LT Debt/Cap

0.0000

Total Debt/Cap

0.0754

Int Coverage

30.0198

CF/Debt

-31.2555

Equity Multi

1.7071

Rec Turnover

0.0000

Pay Turnover

0.3267

Inv Turnover

245000.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-10.3207

FCF/Share

-10.3207

Cash/Share

4.9278

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

-31.2555

ST Coverage

-31.2555

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.0004

P/B

0.0004

P/S

0.0000

P/E

-0.0001

P/FCF

-0.0002

P/OCF

-0.0001

P/CF

-0.0001

PEG

0.0000

P/S

0.0000

EV Multiple

0.4085

P/FV

0.0004

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation